Tirzepatide has emerged as a groundbreaking therapy for type 2 diabetes, offering promising effects. However, the expense of this innovative drug and its access have become key issues for patients and healthcare professionals. While tirzepatide has been approved by regulatory agencies, its high-priced nature presents a significant barrier to many.